High risk of hypoxemic COVID-19 pneumonia in myasthenia gravis patients with type I IFN autoantibodies.

Gervais A, Marchal A, Maillard A, Le Voyer T, Rosain J, Philippot Q, Bizien L, Peel J, Cederholm A, Migaud M, Pons S, Saker K, Laforet P, Aubart M, Gitiaux C, Biggs CM, Lopez RL, Souvannanorath S, Tard C, Pakleza AN, Grapperon AM, Heming N, Annane D, Verschueren A, Attarian S, Bigaut K, Hankiewicz K, Kouton L, Villar-Quiles RN, Cauquil C, Fleury MC, Rocher E, Nicolas G, de Paula Estephan E, da Penha Ananias Morita M, Zanoteli E, Saied Z, Rachdi A, Rim A, Belal S, Ben Sassi S, Hübers A, Faure E, Desguerre I, Basse C, Girard N, Béziat V, Pan-Hammarström Q, Hammarström L, Bodansky A, Parent AV, Anderson MS, DeRisi JL, Demeret S, Truffault F, Fort R, Ader F, Wallet F, Trouillet-Assant S, Abel L, Molina T, Alyanakian MA, Le Panse R, Solé G, Cobat A, Landegren N, Casanova JL, Puel A, Bastard P, Jouanguy E